Unique ID issued by UMIN | UMIN000000871 |
---|---|
Receipt number | R000001048 |
Scientific Title | Prospective Observational Survey on the Long-Term Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome |
Date of disclosure of the study information | 2007/11/01 |
Last modified on | 2012/06/20 20:01:36 |
Prospective Observational Survey on the Long-Term Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome
Prospective Observational Survey on the Thrapeutic Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome - POLARIS Survey -
Prospective Observational Survey on the Long-Term Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome
Prospective Observational Survey on the Thrapeutic Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome - POLARIS Survey -
Japan |
Refractory (drug resistant) nephrotic syndrome
Nephrology |
Others
NO
To survey prospectively the long-term effects of the LDL-apheresis therapy on the drug resistant nephritic syndrome as well as the effects of the background factors of patients and the therapeutic conditions
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Rate of clinical improvement (total number of the complete remission and the type I incomplete remission)
Correlation between the rate of clinical improvement and the following factors which could influence the therapeutic effect
1. stage of nephritic syndrome
2. age
3. severity of renal lesion
4. severity of glomerulosclerosis, degree of tubular damage, selectivity index, etc.
5. TAT (blood coagulation marker) level
6. period between the onset of nephritic syndrome and the application of LDL-application
7. frequency of LDL-apheresis
8. dose of steroids used in combination with LDL-apheresis
9. presence or absence of steroid pulse during LDL-apheresis
Observational
Not applicable |
Not applicable |
Male and Female
Patients who satisfy the criteria for refractory nephrotic syndrome (according to the report of the research and surveillance group for specified diseases, progressive renal impairment, the Ministry of Health, Labor and Welfare) and to whom the doctor in charge applied LDL-apheresis therapy on the basis of the guideline of the therapy for focal segmental glomerulosclerosis
not applicable
200
1st name | |
Middle name | |
Last name | Takao Saito |
Fukuoka University School of Medicine
Division of Nephrology and Rheumatology
7-45-1 Nakakuma, Jonan-ku, Fukuoka 814-0180, Japan
092-801-1011
1st name | |
Middle name | |
Last name | Eri Muso |
Kitano Hospital, The Tazuke Kofukai Medical Research Institute
Division of Nephrology and Dialysis
2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan
06-6312-8824
polaris2001polaris@yahoo.co.jp
the Japanese Society of Kidney and Lipids Research
The Kidney Foundation, Japan
Non profit foundation
Japan
NO
2007 | Year | 11 | Month | 01 | Day |
http://www.jskl.org/research.html
Partially published
Completed
2006 | Year | 12 | Month | 26 | Day |
2007 | Year | 01 | Month | 01 | Day |
2010 | Year | 12 | Month | 01 | Day |
2011 | Year | 06 | Month | 01 | Day |
2011 | Year | 12 | Month | 01 | Day |
2012 | Year | 06 | Month | 01 | Day |
This survey should be performed in compliance with the Helsinki Declaration and the determined protocol.
2007 | Year | 10 | Month | 30 | Day |
2012 | Year | 06 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001048
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |